The firm served as lead counsel for Biotec Pharmacon, ASA, a Norwegian pharmaceutical company, in patent infringement litigation initiated by patent owner Biothera, a Minnesota corporation, in the District of Minnesota in Minneapolis. The 14 patents involved in the litigation relate to, among other things, beta glucan compositions for immunotherapy. The District Court granted summary judgment of non-infringement as to 12 of the 14 patents, and the case subsequently settled.

Biopolymer Eng'g, Inc. v. Immunocorp, No. 05-536 (D. Minn. filed Mar. 14, 2005).

Experience Center

Match our Experience to Your Needs

Experience Highlights

Acquisition for Equifax Inc.
Represented Equifax Inc., one of the United States' largest credit reporting agencies, as buyer's counsel in an acquisition. more
Construction arbitration for Florida construction company
Represented a Florida construction company, specializing in contracting and construction management services, in disputes arising from the more
Sale of interest in a physician owned cath lab for Atlanta Cardiology Group P.C.
Represented Atlanta Cardiology Group P.C. in the sale of majority interest in a physician owned cath lab to more
Class action litigation for YP in California federal court and before the Ninth Circuit Court of Appeals
We represent YP in a class action in federal district court in San Francisco (Northern District of California), which is now pending before the Ninth more